Who won: Oncotype DX Breast recurrence score test

About this contract

Breast Cancer Recurrence Score Test contract ref PTH-22-21-11621 Contract extension taken 1st July 2025

Who won contracts like this

• ✓Answer against the marking scheme, not the question text — Leeds Teaching Hospital NHS Trust scores each response, so map your evidence to the published criteria and weightings.
• ✓At £191,700, expect quality and social value to carry a large share of the score — price alone rarely wins Blood-testing reagents work.
• ✓Show recent, comparable delivery: name similar Blood-testing reagents contracts you've delivered for public bodies, with measurable outcomes.
• ✓This one's been awarded — but Leeds Teaching Hospital NHS Trust retenders on a cycle. Get matched the day the next one lands and start your draft early.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources

Similar contracts